Lifestyle News

TORONTO — A Canadian author and academic is standing by the research in her controversial book about Anne Frank after a Dutch publisher pulled the title in response to the latest round of criticism of its claims about who betrayed the Jewish teenage

NEW YORK (AP) — From the moment the Pulitzer Prize-winning novelist Oscar Hijuelos died in 2013, at age 62, his wife Lori Carlson-Hijuelos has been on a quest to make sure he wasn't forgotten.

NEW YORK (AP) — Of all the Oscar nominees, you would hard pressed to find a more potent film than “The Long Goodbye.” It’s blisteringly visceral, harrowingly violent and desperately urgent — all in under 12 minutes.

PARIS (AP) — French automaker Renault plans to pause production at its Moscow plant in an apparent move to fend off mounting criticism, breaking ranks with other major French companies that have defied pressure to keep operating in Russia after it in

Citing health problems, Alex Jones defied a Connecticut judge's order to show up for a deposition Thursday in a case brought by relatives of victims of the Sandy Hook Elementary School shooting who sued the Infowars host for calling the massacre a ho

LONDON (AP) — The European Union's drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus.

MOSTYSKA, Ukraine (AP) — Russia’s invasion has displaced half of Ukraine’s children. On a hospital bed in a town close to the border with Poland, a little girl with a long blonde braid and dressed in pink is one of them.

NEW YORK (AP) — Once a familiar voice on NPR, Audie Cornish says she signed on to the new CNN+ streaming service in part out of the sense she was helping to open a new frontier.

NEW YORK (AP) — In his Oscar-nominated performance in “CODA,” Troy Kotsur has one spoken line, but it’s a good one.

WASHINGTON (AP) — When patients are battling a terminal illness and want access to an experimental drug, how much evidence that it works should regulators require before approval? That’s the question behind many of the Food and Drug Administration’s